Acadia delays U.S. application to market lead drug, CEO retires

(Reuters) - Acadia Pharmaceuticals Inc said it delayed the submission of a U.S. application to market its lead drug, nuplazid, and that its chief executive was retiring.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1KYhkj0